• FDA approves Vanda Pharmaceuticals’ FANAPT (iloperidone) for schizophrenia, shares soar over 800% in after-hours trading! [Yahoo!Finance]

• VeroScience, in collaboration with S2 Therapeutics, has received FDA approval for Cycloset™, a quick-release oral formulation of bromocriptine mesylate for the treatment of Type 2 diabetes. [BioSpace]

• CombinatoRx gets $4M upfront from Novartis in R& deal. [BizJournals]

• Genzyme and Ergomed sign co-development deal for tasidotin, an investigational drug for melanoma. [Genetic Engineering & Biotechnology News]

• Shares of Cell Therapeutics shot up over 100% today on continuing rumors of a Pixantrone deal with Novartis, OPAXIO approval in Europe. [Yahoo!Finance]

• Sequenom gets another lawsuit, this one from Abbey Spanier Rodd & Abrams, LLP, shareholder suits mounting. [Pharmalive]

• Finally, Eli Lilly says it’s paying the state of Georgia $6M in a settlement over marketing of anti-psychotic drug Zyprexa. [AJC]

Image from vandapharma

Related Posts